12/05/2018 | Press release | Distributed by Public on 12/05/2018 11:37
The Health and Social Care Secretary Matt Hancock has announced that the 100,000 Genomes Project has reached its goal of sequencing 100,000 whole genomes from NHS patients.
The 100,000 Genomes Project uses whole genome sequencing technology to improve diagnoses and treatments for patients with rare inherited diseases and cancer. It is led by Genomics England and NHS England.
Since the project was launched in 2012 it has delivered life-changing results for patients who have had their genomes sequenced, with 1 in 4 patients with a rare disease receiving a diagnosis for the first time.
Thirteen NHS Genomic Medicine Centres (GMCs) were created to support the project, along with a state-of-the-art sequencing centre and an automated analytics platform to return genome analyses to the NHS.
The UK is the first nation in the world to apply whole genome sequencing at scale in direct healthcare. Genomics can enable doctors to identify those at risk of disease, help prevent it and provide personalised treatments to give patients the best chance of recovery.
To build on the project's success, in October the Secretary of State set out an ambition to sequence 5 million genomes in the UK over the next 5 years. The health secretary also announced the launch of the NHS Genomic Medicine Service. This will see all seriously ill children and adults with certain rare diseases or cancers offered whole genome sequencing as part of their care from 2019.
Health and Social Care Secretary Matt Hancock said:
Sequencing the 100,000th genome is a major milestone in the route to the healthcare of the future. From Crick and Watson onwards, Britain has led the world in this amazing technology. We do so again today as we map a course to sequencing a million genomes. Understanding the human code on such a scale is part of our mission to provide truly personalised care to help patients live longer, healthier and happier lives.
I'm incredibly excited about the potential of this type of technology to unlock the next generation of treatments, diagnose diseases earlier, save lives and enable patients to take greater control of their own health.
Sir John Chisholm, Chair of Genomics England, said:
At launch the 100,000 Genomes Project was a bold ambition to corral the UK's renowned skills in genomic science and combine them with the strengths of a truly national health service in order to propel the UK into a global leadership position in population genomics.
With this announcement, that ambition has been achieved. The results of this will be felt for many generations to come as the benefits of genomic medicine in the UK unfold.